These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7581125)

  • 1. Induction of cutaneous 'graft-versus-host like' reaction by recombinant IL-2 after autologous bone marrow transplantation.
    Costello R; Blaise D; Jacquemier J; Monges G; Stoppa AM; Viens P; Olive D; Bouabdallah M; Brandely ; Gastaut JA
    Bone Marrow Transplant; 1995 Jul; 16(1):199-200. PubMed ID: 7581125
    [No Abstract]   [Full Text] [Related]  

  • 2. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation.
    Takatsuka H; Takemoto Y; Yamada S; Mori A; Wada H; Fujimori Y; Okamoto T; Kanamaru A; Kakishita E
    Hematology; 2002 Feb; 7(1):55-7. PubMed ID: 12171778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin and stomach graft versus host disease after syngeneic BMT in CML: a case report.
    Pelosini M; Galimberti S; Benedetti E; Caracciolo F; Fazzi R; Petrini M; Papineschi F
    Leuk Res; 2007 Nov; 31(11):1603-4. PubMed ID: 17328949
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokine expression in human cutaneous chronic graft-versus-host disease.
    Ochs LA; Blazar BR; Roy J; Rest EB; Weisdorf DJ
    Bone Marrow Transplant; 1996 Jun; 17(6):1085-92. PubMed ID: 8807119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The skin manifestations of the graft vs. host reaction].
    Biriukov AV; Baranov AE; Selidovkin GD; Evseeva LV; Getling ZM; Persina IS
    Vestn Dermatol Venerol; 1990; (5):16-9. PubMed ID: 2402935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast media triggering cutaneous graft-versus-host disease.
    Vavricka SR; Halter J; Furrer K; Wolfensberger U; Schanz U
    Bone Marrow Transplant; 2002 Jun; 29(11):899-901. PubMed ID: 12080354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer.
    Wu JM; Bensen-Kennedy D; Miura Y; Thoburn CJ; Armstrong D; Vogelsang GB; Hess AD
    Biol Blood Marrow Transplant; 2005 Jun; 11(6):455-64. PubMed ID: 15931634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
    Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired ichthyosis in bone marrow transplant recipients.
    Spelman LJ; Strutton GM; Robertson IM; Weedon D
    J Am Acad Dermatol; 1996 Jul; 35(1):17-20. PubMed ID: 8682957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of acute grade IV skin and eye graft-versus-host disease by anti-interleukin-2 receptor monoclonal antibody in genoidentical bone marrow transplantation setting.
    Ozşahin H; Tuchschmid P; Lauener R; Waldvogel K; Nadal D; Seger RA
    Turk J Pediatr; 1998; 40(2):231-5. PubMed ID: 9677728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous chronic graft-versus-host disease localized to the field of total lymphoid irradiation.
    Okamoto S; Takahashi S; Inoue T; Tojo A; Tani K; Kikuchi A; Shimizu H; Nishikawa T; Ikeda Y; Asano S
    Bone Marrow Transplant; 1996 Jan; 17(1):111-3. PubMed ID: 8673042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.
    Tanaka J; Imamura M; Kasai M; Zhu X; Kobayashi S; Imai K; Hashino S; Higa T; Sakurada K; Miyazaki T
    Bone Marrow Transplant; 1994 Nov; 14(5):695-701. PubMed ID: 7889002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of interleukin-10 in acute graft-versus-host disease and graft rejection.
    Ju X; Wang J; Xu B; Cao Y; Lü S
    Chin Med J (Engl); 2003 Apr; 116(4):534-7. PubMed ID: 12875717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 for prevention of graft-versus-host disease after haploidentical marrow transplantation.
    Przepiorka D; Ippoliti C; Koberda J; Chan KW; Khouri IF; Fischer HE; Huh YO; Escudier SM; Seong D; Davis M
    Transplantation; 1994 Oct; 58(7):858-60. PubMed ID: 7940725
    [No Abstract]   [Full Text] [Related]  

  • 17. Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease.
    Bonanomi S; Balduzzi A; Tagliabue A; Biagi E; Rovelli A; Corti P; Crippa D; Uderzo C
    Bone Marrow Transplant; 2001 Sep; 28(6):631-2. PubMed ID: 11607781
    [No Abstract]   [Full Text] [Related]  

  • 18. Lichenoid graft-vs-host disease in an autologous bone marrow transplant recipient.
    Martin RW; Farmer ER; Altomonte VL; Vogelsang GB; Santos GW
    Arch Dermatol; 1995 Mar; 131(3):333-5. PubMed ID: 7887664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
    Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
    Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.
    Voltarelli JC; Ahmed H; Paton EJ; Stracieri AB; Holman P; Bashey A; Coutinho M; Simoes BP; Ball ED; Carrier E
    Bone Marrow Transplant; 2001 Jul; 28(1):97-9. PubMed ID: 11498752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.